- $29.32bn
- $28.61bn
- $606.42m
Annual balance sheet for Insmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 717 | 1,148 | 780 | 1,434 | 1,430 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 24.4 | 29.7 | 41.2 | 52 | 141 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 837 | 1,273 | 929 | 1,622 | 1,794 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 95.5 | 102 | 104 | 116 | 139 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,244 | 1,656 | 1,330 | 2,025 | 2,265 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Current Liabilities | 135 | 190 | 226 | 298 | 469 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 833 | 1,568 | 1,662 | 1,740 | 1,526 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 410 | 88 | -332 | 285 | 739 |
| Total Liabilities & Shareholders' Equity | 1,244 | 1,656 | 1,330 | 2,025 | 2,265 |
| Total Common Shares Outstanding |